CStone Pharmaceuticals announced the IND approval of CS5001, a...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SUZHOU, China, Jan. 3, 2022 /PRNewswire-AsiaNet/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigationa...
Authors: LATEST ASIANET NEWS RELEASES